POSTERIOR SUB-TENON'S Avastin

Asociación para Evitar la Ceguera en México

Status and phase: Withdrawn; Phase 4

Conditions: Diffuse Diabetic Macular Edema

Treatments: Drug: bevacizumab (Sub-tenon´s injection)

Study type: Interventional

Funder types: Other

Identifiers

NCT00567372

00922

Details and patient eligibility

About

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

Sex: All

Ages: 25 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients with diffuse diabetic macular edema non-proliferative diabetic retinopathy Maculat thickness ≥250 μ BCVA ≥ 20/400 Without any treatment

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)